NuevaBio is an investment company established by a team of experienced founders in the biopharmaceutical industry. The organization specializes in founding, seeding, and growing innovative companies, particularly in the fields of metabolic disease and mitochondrial health. Notable portfolio companies include OrsoBio, which develops metabolic therapies for obesity, and MitoPower, focused on mitochondrial health solutions.

NuevaBio's primary focus areas include the development of therapeutics for metabolic diseases, obesity, type 2 diabetes, and disorders associated with mitochondrial dysfunction. The organization aims to leverage the extensive experience of its founders to create and support companies that address these critical health challenges.

NuevaBio offers significant support in the form of funding, mentorship, and access to a network of industry experts. The organization is particularly focused on helping founders navigate the complexities of drug development and company formation in the biopharmaceutical sector.

Q: What types of companies does NuevaBio invest in? A: NuevaBio primarily invests in biopharmaceutical companies focused on therapeutics for metabolic diseases and mitochondrial dysfunction. Q: How does NuevaBio support its portfolio companies? A: NuevaBio provides funding, mentorship, and access to a network of industry experts to help companies grow and succeed.